Elsevier BV provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of European Neuropsychopharmacology (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers European Neuropsychopharmacology published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Psychiatryrank 219 of 293 journals
- Clinical Neurologyrank 225 of 297 journals
- Pharmacology & Pharmacyrank 307 of 371 journals
- Neurosciencesrank 285 of 321 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of European Neuropsychopharmacology
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). European Neuropsychopharmacology is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Article processing charge listed at about US$3,000.
02Fee waivers
APC waivers and discounts for European Neuropsychopharmacology
European Neuropsychopharmacology follows the waiver policy of its publisher, Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country.
Authors affiliated in 82 countries qualify for a full waiver. See the countries →
Waivers apply to fully open access journals. If European Neuropsychopharmacology is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Retractions and research integrity at European Neuropsychopharmacology
Most common reasons (a retraction can have several):
European Neuropsychopharmacology has 1 retracted paper in the Retraction Watch database, the latest in Aug 2022. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
Who funds research published in European Neuropsychopharmacology
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to European Neuropsychopharmacology? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
03Indexing
Indexing of European Neuropsychopharmacology
- ISSN
- 0924-977X
- eISSN
- 1873-7862
- Publisher
- Elsevier BV all its journals →
- Subjects
- Clinical Neurology, Neurosciences, Pharmacology & Pharmacy, Psychiatry
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to European Neuropsychopharmacology
- Read the guide for authors. It sets the article types, word limit, reference style and file format that European Neuropsychopharmacology accepts. Open the official guide for authors and submit from the same page.
- Use the journal's template. Elsevier BV offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. European Neuropsychopharmacology is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05Reviewer comments
Reviewer comments and rejection reasons for European Neuropsychopharmacology
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Planning to submit to European Neuropsychopharmacology? A Manuscript Audit by a PhD reviewer in your area checks your paper for the issues reviewers raise most often.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
06Same subject
Psychiatry journals with a similar impact factor*
The journals next to European Neuropsychopharmacology when the 279 journals of Psychiatry in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 215 | Drug and Alcohol Dependence | 1.04 | SCIE, SSCI | Subscription |
| 216 | Mental Illness | 1.04 | ESCI | Fully open access |
| 217 | Traumatology An International Journal | 1.03 | ESCI | Subscription |
| 218 | Psychiatria Polska | 1.01 | SCIE | Some open access |
| 220 | Experimental and Clinical Psychopharmacology | 0.99 | SCIE, SSCI | Subscription |
| 221 | Brazilian Journal of Psychiatry | 0.99 | SCIE, SSCI | Fully open access |
| 222 | BJPsych Bulletin | 0.97 | ESCI | Fully open access |
| 223 | Perspectives In Psychiatric Care | 0.95 | SCIE, SSCI | Subscription |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
07Journal Finder
Find the right journal for your paper
Is European Neuropsychopharmacology right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,724 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
What is the impact factor of European Neuropsychopharmacology?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of European Neuropsychopharmacology is 1.00: papers it published in the two previous years were cited 1.00 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of European Neuropsychopharmacology?
The h-index of European Neuropsychopharmacology is 157 (OpenAlex, October 2026): 157 of its papers have each been cited at least 157 times. Its i10-index is 3,213.
What is the APC of European Neuropsychopharmacology?
OpenAlex lists an article processing charge (APC) of about US$3,000 for European Neuropsychopharmacology (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of European Neuropsychopharmacology?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). European Neuropsychopharmacology is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is European Neuropsychopharmacology indexed in Scopus?
Yes. European Neuropsychopharmacology appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is European Neuropsychopharmacology an SCIE journal?
Yes. European Neuropsychopharmacology is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is European Neuropsychopharmacology in Journal Citation Reports (JCR)?
Yes. European Neuropsychopharmacology is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does European Neuropsychopharmacology offer an APC waiver?
European Neuropsychopharmacology follows the policy of Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country. Rules verified 27 October 2026; confirm on the publisher's page.
Has European Neuropsychopharmacology retracted papers?
Yes. The Retraction Watch database lists 1 retracted paper in European Neuropsychopharmacology, 1 of them in the last 10 years; the most common reasons are concerns/issues about data. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in European Neuropsychopharmacology?
12% of 200 recent research articles in European Neuropsychopharmacology name a funder in Crossref; the funders named most often are National Institutes of Health, Carlos III Health Institute, Johnson and Johnson.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Electronics Letters
- BMJ
- Chemical Communications
- Physics Today
- Energies
- Nucleic Acids Research
- Analytica Chimica Acta
- Journal of Applied Polymer Science
- Gastroenterology
- Thin Solid Films
- Journal of Physical Chemistry
- Ceramics International
- Journal of Physical Chemistry B
- Journal of Applied Physics
Browse all journals: indexing, impact factor and reviewer comments →